Pharma and Digital Health-Yan Chow, MD-07/11/2017 - 6:00pm

Event Information
Event Topic: 
Pharma and Digital Health
Event Date: 
07/11/2017 - 6:00pm
Event Location: 
Wilson Sonsini Goodrich & Rosati - 650 Page Mill Road, Palo Alto
Speaker Information
Event Speaker: 
Yan Chow, MD
Event Speaker Title: 
Medical Director for Digital Health in the Medical Sciences Early Development
Event Speaker Company: 
Event Speaker Bio: 

Yan Chow, MD, MBA is Medical Director for Digital Health in the Medical Sciences Early Development group at Amgen, the world's largest independent biotechnology company, where he studies the use of wearables, devices, mobile technology, and analytics in clinical trials and programs. Amgen's areas of focus include oncology, cardiovascular disease, inflammation, bone disease, nephrology, and neuroscience.

Before that, he was Chief Innovation Officer at LongView Technology Solutions, a federal health IT services contractor.

Prior to LongView, Dr. Chow was national Medical Director of the Innovation & Advanced Technology Group (IAT) at Kaiser Permanente. IAT assessed over 2,000 emerging health IT technologies, promoted innovation through an employee innovation grant program, and worked with the Garfield Innovation Center, an award-winning care delivery simulation laboratory.

Dr. Chow has founded and advised a number of startups. He has 3 U.S. patents and has been an invited speaker at industry conferences. Dr. Chow earned an A.B. from Harvard University, his M.D. from UC San Diego, and his MBA in 2005 from UC Berkeley.

Event Details
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins
Event Details: 

In today's turbulent healthcare landscape, every stakeholder from care providers to payers to patients is on new ground. The life sciences industry is an important part of this ecosystem in generating new therapeutic agents for cancer, heart disease, and many other serious conditions. This talk will discuss why business as usual will not be possible for pharma/biotech companies in the future, and the critical role that digital technologies will play. The objective will be to better understand the factors motivating pharma today.